<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03688269</url>
  </required_header>
  <id_info>
    <org_study_id>P/2018/384</org_study_id>
    <nct_id>NCT03688269</nct_id>
  </id_info>
  <brief_title>Minimal Effective Concentration (EC90) of Ropivacaine</brief_title>
  <acronym>AxiRopiDexa</acronym>
  <official_title>Determination of the Minimal Effective Concentration (EC90) of Ropivacaine in Axillary Brachial Plexus Block With Intravenous Dexamethasone or Saline Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective up and down sequential evaluation of the minimal effective concentration of
      perineural ropivacaine for 90% success in axillary brachial plexus block with the injection
      of intravenous dexamethasone or saline placebo during regional anesthesia performance
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ropivacaine concentration determined by up and down sequential method dexamethasone or saline
      placebo determined by randomisation
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 5, 2018</start_date>
  <completion_date type="Anticipated">March 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>allocation to one of the 2 arm after randomization</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical Effectiveness of regional anesthesia at 30min</measure>
    <time_frame>Time of surgery</time_frame>
    <description>Ability to perform surgery under regional anaesthesia without supplementary anaesthesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time between regional anesthesia and surgical incision</measure>
    <time_frame>Time of surgery</time_frame>
    <description>time between the end of regional anesthesia and the beginning of surgical incision</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effectiveness of regional anaesthesia on Pin-Prick sense</measure>
    <time_frame>Time of anaesthesia</time_frame>
    <description>Defined by a loss of pain sensation at the pinprick test at 30min after the end of regional anaesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effectiveness of regional anaesthesia on cold sensation</measure>
    <time_frame>Time of anaesthesia</time_frame>
    <description>Defined by a loss of sensation of cold application on skin at 30min after the end of regional anaesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effectiveness of regional anaesthesia on motor function</measure>
    <time_frame>Time of anaesthesia</time_frame>
    <description>Defined by a paresis at 30min after the end of regional anaesthesia (modified bromage score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recovery of regional anesthesia: pain</measure>
    <time_frame>first 48h</time_frame>
    <description>time to first pain sensation in the surgical wound after the end of regional anaesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recovery of regional anesthesia: motor</measure>
    <time_frame>first 48h</time_frame>
    <description>time to motor recovery of the arm after the end of regional anaesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recovery of regional anesthesia: sensory</measure>
    <time_frame>first 48h</time_frame>
    <description>time to sensory recovery of the arm after the end of regional anaesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication related to regional anesthesia and/or intravenous dexamethasone</measure>
    <time_frame>month 6</time_frame>
    <description>any complication during the first 6 month after the surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Anesthesia, Conduction</condition>
  <condition>Ropivacaine</condition>
  <condition>Dexamethasone</condition>
  <condition>Axillary Brachial Plexus Block</condition>
  <arm_group>
    <arm_group_label>Intravenous dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Axillary Brachial Plexus Block with perineural Ropivacaine. Concentration determined by sequential up and down method.
Intravenous injection of 8mg/2ml Dexamethasone during the regional anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Axillary Brachial Plexus Block with perineural Ropivacaine. Concentration determined by sequential up and down method.
Intravenous injection of 2ml Saline 0.9% during the regional anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous dexamethasone</intervention_name>
    <description>Intravenous injection of 8mg/2ml dexamethasone</description>
    <arm_group_label>Intravenous dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous saline</intervention_name>
    <description>Intravenous injection of 2ml Saline 0.9%</description>
    <arm_group_label>Intravenous saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Perineural ropivacaine</intervention_name>
    <description>Perineural injection of 20ml ropivacaine with adjustment of the concentration determined by sequential up and down method</description>
    <arm_group_label>Intravenous dexamethasone</arm_group_label>
    <arm_group_label>Intravenous saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years old or older

          -  ASA Score 1,2 et 3 (American Society of Anesthesiologists Score)

          -  surgery under axillary brachial plexus block

          -  signed information consent

        Exclusion Criteria:

          -  pregnancy and breastfeeding

          -  contraindication to regional anesthesia or technical impossibility

          -  impaired coagulation

          -  delay of surgery to short to allow regional anesthesia

          -  dementia or under administrative supervision

          -  allergy and contraindication to dexamethasone or ropivacaine

          -  total dose of ropivacaine higher than 3 mg / kg (recommended dose for upper limb
             regional anesthesia)

          -  opioids or pain killers abuse or addiction

          -  steroids consumption in the past 6 months

          -  surgery estimated to be greater than 4 hours

          -  anticipated bad observation of treatment

          -  patient enrolled in another trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francis BERTHIER</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Besancon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francis BERTHIER</last_name>
    <phone>3 81 21 89 80</phone>
    <phone_ext>+33</phone_ext>
    <email>f1berthier@chu-besancon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lucie VETTORETTI</last_name>
    <phone>3 81 21 83 78</phone>
    <phone_ext>+ 33</phone_ext>
    <email>lvettoretti@chu-besancon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis BERTHIER</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>September 14, 2018</study_first_submitted>
  <study_first_submitted_qc>September 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2018</study_first_posted>
  <last_update_submitted>October 12, 2018</last_update_submitted>
  <last_update_submitted_qc>October 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>regional anesthesia</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>ropivacaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD sharing in progress in the institution</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

